GRAIL, Inc. (GRAL): restructuring charge — GRAIL expects $888.9M goodwill impairment & ~$420M IPR&D charge in Q2 2024

GRAIL, Inc.

Goodwill impairment charge of $888.9 million, full remaining carrying value as of March 31, 2024.
IPR&D intangible impairment estimated at ~$420 million pushed down from Illumina's spin-off.
Total IPR&D intangible assets were $560.0 million as of March 31, 2024.
No material future cash expenditures expected from these impairments.

item 2.06

Key facts

Extracted from this filing and checked against the source text.

Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.9

GRAIL, Inc. announced a impairment with charges of approximately $420.0 million affecting IPR&D intangible assets.

Type: impairment
Charge: approximately $420.0 million
Affected area: IPR&D intangible assets

Exact text from the filing

Illumina disclosed that it expects to recognize an impairment charge for IPR&D intangible assets of approximately $420.0 million in connection with the Spin-Off, and such charge will also be pushed down to the Company and recorded in the second quarter

View on SEC.gov

Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.9

GRAIL, Inc. announced a impairment with charges of $888.9 million affecting goodwill.

Type: impairment
Charge: $888.9 million
Affected area: goodwill

Exact text from the filing

the Company estimates that it will recognize a goodwill impairment charge in the second quarter of 2024 equal to $888.9 million, or the full remaining carrying value of goodwill as of March 31, 2024

View on SEC.gov

3 restructurings & charges filed in the last 30 days. Browse all restructurings & charges →

GRAIL, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-030355

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.